Salazosulfapyridine induced hypersensitivity syndrome associated with reactivation of humanherpes virus 6

Internal Medicine

Volumn 42, Issue 2, 2003, Pages 203-207

  Kunisaki, Yuya ^b   Goto, Hiroshi ^b   Kitagawa, Kikuo ^a   Nagano, Masanori ^b  

^a Kitagawa Clinic   (Japan)

^b KYUSHU KOSEI NENKIN HOSPITAL   (Japan)

Author keywords

Human herpesvirus 6; Hypersensitivity syndrome; Salazosulfapyridine; Severe drug eruption

Indexed keywords

ANTIALLERGIC AGENT; CORTICOSTEROID; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; SALAZOSULFAPYRIDINE; STEROID;

ADULT; ANTIBODY TITER; ARTICLE; CASE REPORT; DISEASE SEVERITY; DRUG PULSE THERAPY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN HERPESVIRUS 6; HUMAN TISSUE; HYPERSENSITIVITY REACTION; LIVER INJURY; LYMPHOCYTE ACTIVATION; RASH; ULCERATIVE COLITIS; VIRUS REACTIVATION;

EID: 0345421269     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.42.203     Document Type: Article

References (18)

1. Tohyama M, Hashimoto K. Hypersensitivity syndrome. Clin Dermatol 53: 45-49, 1999 (in Japanese).
2. Suzuki Y, Inagi R, Aono T, Yamanishi K, Shiohara T. Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome. Arch Dermatol 134: 1108-1112, 1998.
3. Tohyama M, Yahata Y, Yasukawa M, et al. Severe hypersensitivity syndrome due to salfasalazine associated with reactivation of human herpesvirus 6. Arch Dermatol 134: 1113-1117, 1998.
4. Matsuo S, Nakayama H, Imai T. Two cases of severe drug eruption due to salazopyrin, associated with ulcerative-colitis. Clin Dermatol 35: 1135-1143, 1981 (in Japanese).
5. Tamaki A, Yamamoto M. Drug eruption due to salazosulfapyridine. Rinsho Derma (Tokyo) 34: 479-482, 1992 (in Japanese).
6. Hakuno M, Kikuchi H, Ide E, et al. Drug eruption due to salazosulfapyridine mimicking infectious mononucleosis. Rinsho Derma (Tokyo) 36: 1219-1223, 1994 (in Japanese).
7. Uchida A, Fujii S, Adachi Y, et al. A case of ulcerative colitis complicated by fever, erythroderma and liver dysfunction caused by salazopyrin. Gastroenterol Endoscopy 7: 763-768, 1995 (in Japanese, Abstract in English).
8. Ito Y, Asano K, Matsuo S, Naruse H, Iizuka H. Drug eruption due to salazosulfapyridine mimicking infectious mononucleosis. Rinsho Derma (Tokyo) 38: 1057-1060, 1996 (in Japanese).
9. Hara H, Tanabe K, Doi M, et al. Drug eruption due to salazosulfapyridine mimicking infectious mononucleosis. Rinsho Derma (Tokyo) 40: 77-81, 1998 (in Japanese).
10. Tokimitsu R, Yoshihara N, Higaki Y, Kawashima M. A case of drug eruption due to salazosulfapyridine. Jpn J Dermatoallergol 8: 71-74, 2000 (in Japanese, Abstract in English).
11. Futei Y, Taguchi H, Konohana I. Two cases of drug eruption due to salazosulfapyridine, showing infectious mononucleosis-like symptoms. Clin Dermatol 54: 147-149, 2000 (in Japanese).
12. Rubin R. Sulfasalazine-induced fulminant hepatic failure and necrotizing pancreatitis. Am J Gastroenterol 89: 789-791, 1994.
13. Fujino Y, Yamada T. Neurological complications of ulcerative colitis. Nippon Rinsho 57: 2532-2535, 1999 (in Japanese).
14. Chad DA, Smith TW, DeGirolami U, Hammer K. Perineuritis and ulcerative colitis. Neurology 36: 1377-1379, 1986.
15. Frenkel N, Schirmer EC, Katsafanas G, June CH. T-cell activation is required for efficient replication of human herpesvirus 6. J Virol 64: 4598-4602, 1990.
16. Wolkenstein P, Charue D, Laurent P, Revuz J, Roujeau JC, Bagot M. Metabolic predisposition to cutaneous adverse drug reaction. Role in toxic epidermal necrolysis caused by sulfonamides and anticonvulsants. Arch Dermatol 131: 544-551, 1995.
17. Schröder H, Evans DA. Acetylator phenotype and adverse effects of sulphasalazine in healthy subjects. Gut 13: 278-284, 1972.
18. Azad Khan AK, Nurazzaman M, Truelove SC. The effect of the acetylator phenotype on the metabolism of sulphasalazine in man. J Med Genet 20: 30-36, 1983.